In a French hospital, a human coder might spend hours translating a patient’s chart into the precise alphanumeric codes that trigger insurance reimbursement. It is a tedious, error-prone task, and the software it runs on is often decades old, resistant to modern integration. Parallel, a Paris-based startup, is betting that the most practical path to automation is not to replace these systems, but to teach an AI to use them like a person would, clicking and typing through a virtual desktop. The company’s recently closed $20M Series A, led by Index Ventures, is a vote of confidence that this patient, pragmatic approach can unlock efficiency in one of healthcare’s most stubborn administrative bottlenecks.
The Wedge of Agentic RPA
Parallel’s core technical premise is what it calls Agentic RPA. Instead of building a complex API integration with a hospital’s legacy patient management or billing software, its AI agents operate via a remote connection that emulates mouse movements and keyboard inputs. This allows deployment in about one week, the company says, positioning the product as a swift, surgical layer atop entrenched technology. The initial and primary application is medical coding, where the AI ingests clinical notes, suggests appropriate reimbursement codes, and submits them through the existing hospital interface. For CFOs and medical directors, the promise is direct: improved coding accuracy translates to captured revenue and, the company claims, a potential 30% reduction in administrative burden.
A Team Built for the Grind
The founders bring a complementary blend of technical scale and healthcare operations experience. CEO Paul Lafforgue is an École Polytechnique and HEC graduate with a background in search data projects at Meta and strategy at McKinsey. His co-founder and CTO, Christopher Rydahl, previously founded Hublo, which grew into Europe’s largest healthcare staffing platform. They are joined by Chief Medical Officer Quentin Jarrion, a former CMIO of Ramsay Santé, France’s largest private hospital group.
| Role | Name | Key Background |
|---|---|---|
| Co-Founder & CEO | Paul Lafforgue | Ex-Meta, ex-McKinsey, École Polytechnique/HEC |
| Co-Founder & CTO | Christopher Rydahl | Founder of Hublo |
| Chief Medical Officer | Quentin Jarrion | MD, former CMIO of Ramsay Santé |
Early Traction in a Fragmented Market
Parallel reports its AI agents are already live in dozens of public and private hospitals. Its published case studies include partnerships with Centre Hospitalier de Dunkerque and Groupe Hospitalier Diaconesses Croix Saint-Simon in France. The $23.5M in total disclosed funding, following a Y Combinator batch in Winter 2024, provides a substantial runway to scale these deployments.
The Skeptic’s Checklist
For all its promise, Parallel’s bet faces real-world tests that go beyond technical demonstration. The regulatory context for AI in medical coding is complex, involving compliance with data privacy laws like GDPR and ensuring audit trails for billing decisions.
- Accuracy and auditability. An AI making coding errors could lead to claim denials or compliance issues.
- Scalability of emulation. Managing thousands of unique, evolving legacy software instances via remote desktop could become an operational burden.
- Competitive landscape. Parallel’s differentiation rests entirely on its non-integration method and European focus.
For patients, the disease state here is administrative bloat. Parallel’s ambition is to make the translation of clinical notes into reimbursement codes instantaneous and invisible, freeing human effort for the patient-facing work that no AI can replicate.